SG11201804184SA - New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 - Google Patents

New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3

Info

Publication number
SG11201804184SA
SG11201804184SA SG11201804184SA SG11201804184SA SG11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA SG 11201804184S A SG11201804184S A SG 11201804184SA
Authority
SG
Singapore
Prior art keywords
international
4ekdo
kdo
ara
synthesis
Prior art date
Application number
SG11201804184SA
Other languages
English (en)
Inventor
Boris Vauzeilles
Pons Jordi Mas
Aurélie Baron
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of SG11201804184SA publication Critical patent/SG11201804184SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/027Keto-aldonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201804184SA 2015-11-17 2016-11-16 New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 SG11201804184SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15306824.2A EP3170830A1 (en) 2015-11-17 2015-11-17 New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds ; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3
PCT/EP2016/077900 WO2017085144A1 (en) 2015-11-17 2016-11-16 New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3

Publications (1)

Publication Number Publication Date
SG11201804184SA true SG11201804184SA (en) 2018-06-28

Family

ID=55024958

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804184SA SG11201804184SA (en) 2015-11-17 2016-11-16 New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3

Country Status (11)

Country Link
US (1) US10717718B2 (zh)
EP (2) EP3170830A1 (zh)
JP (1) JP6923520B2 (zh)
KR (1) KR20180095508A (zh)
CN (1) CN108431014B (zh)
AU (1) AU2016358039B2 (zh)
BR (1) BR112018010056B1 (zh)
CA (1) CA3005500A1 (zh)
SG (1) SG11201804184SA (zh)
WO (1) WO2017085144A1 (zh)
ZA (1) ZA201803250B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113677997A (zh) * 2019-02-20 2021-11-19 迪亚米德克斯 使用修饰的单糖化合物用于标记来自多细胞生物的真核细胞以及用于治疗和/或诊断癌症的方法
IL299328A (en) * 2020-07-07 2023-02-01 Theraonco Methods for treating cancer using an adapted monosaccharide compound
WO2024105051A1 (en) * 2022-11-15 2024-05-23 Ecole Polytechnique Federale De Lausanne (Epfl) Method for preparing an at least partially acetal-protected sugar

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2617833A1 (en) * 2012-01-18 2013-07-24 Centre National de la Recherche Scientifique (CNRS) A method for specifically detecting living bacteria

Also Published As

Publication number Publication date
BR112018010056A2 (pt) 2018-11-13
US20180370942A1 (en) 2018-12-27
BR112018010056B1 (pt) 2022-11-08
JP2018534312A (ja) 2018-11-22
EP3170830A1 (en) 2017-05-24
CA3005500A1 (en) 2017-05-26
US10717718B2 (en) 2020-07-21
WO2017085144A1 (en) 2017-05-26
CN108431014B (zh) 2021-08-10
EP3377507B1 (en) 2021-12-08
AU2016358039A1 (en) 2018-06-07
AU2016358039B2 (en) 2020-10-15
KR20180095508A (ko) 2018-08-27
JP6923520B2 (ja) 2021-08-18
CN108431014A (zh) 2018-08-21
EP3377507A1 (en) 2018-09-26
ZA201803250B (en) 2019-06-26

Similar Documents

Publication Publication Date Title
SG11201408539UA (en) Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
SG11201804373VA (en) Compositions and methods for immunooncology
SG11201805838UA (en) Macrocyclic mcl1 inhibitors for treating cancer
SG11201908640TA (en) Pyrrolidinones and a process to prepare them
SG11201808582RA (en) Pyrrolotriazine compounds as tam inhibitors
SG11201809714TA (en) Piperidines as menin inhibitors
SG11201407534PA (en) New diazaspirocycloalkane and azaspirocycloalkane
SG11201807426WA (en) Immunomodulators
SG11201805595TA (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
SG11201804901WA (en) Compounds for the treatment of cancer and inflammatory disease
SG11201408094YA (en) Neprilysin inhibitors
SG11201808566WA (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
SG11201407546QA (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
SG11201809499UA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201810389XA (en) New antibacterial compounds
SG11201909807TA (en) Methods of manufacturing of niraparib
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201909083UA (en) Piperidines as covalent menin inhibitors
SG11201808686VA (en) Synthesis of indazoles
SG11201406945QA (en) Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201804184SA (en) New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3
SG11201805387RA (en) Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
SG11201407575PA (en) 5-amino[1,4]thiazines as bace 1 inhibitors
SG11201901460UA (en) Method for producing the crystalline form of modification a of calcobutrol